Tempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 33,284 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 33,284 shares of the firm’s stock in a transaction dated Wednesday, July 8th. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76. Following the sale, the chief executive officer owned 167,763 shares of the company’s stock, valued at approximately $9,627,918.57. This represents a 16.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The shares were sold at an average price of $60.00, for a total value of $600,000.00.
• On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The stock was sold at an average price of $44.07, for a total value of $597,148.50.

Tempus AI Stock Performance

Shares of Tempus AI stock traded down $3.27 during trading on Friday, reaching $58.23. The company’s stock had a trading volume of 4,376,376 shares, compared to its average volume of 5,896,411. Tempus AI, Inc. has a 52 week low of $41.73 and a 52 week high of $104.32. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96. The business’s 50-day moving average price is $51.29 and its 200-day moving average price is $54.35. The firm has a market cap of $10.46 billion, a PE ratio of -33.85 and a beta of 3.46.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.08. The business had revenue of $348.12 million during the quarter, compared to analysts’ expectations of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm’s revenue for the quarter was up 36.1% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.24) earnings per share. Equities analysts forecast that Tempus AI, Inc. will post -1.35 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently commented on TEM. Weiss Ratings reissued a “sell (e+)” rating on shares of Tempus AI in a report on Wednesday, June 17th. BTIG Research restated a “buy” rating and issued a $80.00 target price on shares of Tempus AI in a research report on Monday, June 1st. HC Wainwright lowered their price target on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a report on Monday, May 11th. Jefferies Financial Group initiated coverage on Tempus AI in a report on Monday, April 13th. They set an “underperform” rating and a $35.00 price objective on the stock. Finally, TD Cowen boosted their price target on Tempus AI from $65.00 to $68.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Nine research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Tempus AI has an average rating of “Hold” and an average target price of $68.54.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of TEM. Aberdeen Group plc raised its position in shares of Tempus AI by 64.2% in the 4th quarter. Aberdeen Group plc now owns 263,004 shares of the company’s stock worth $15,530,000 after acquiring an additional 102,878 shares in the last quarter. Pictet Asset Management Holding SA lifted its position in shares of Tempus AI by 291.3% during the 4th quarter. Pictet Asset Management Holding SA now owns 48,488 shares of the company’s stock valued at $2,948,000 after acquiring an additional 36,096 shares during the period. Bogart Wealth LLC grew its holdings in Tempus AI by 365,087.5% in the fourth quarter. Bogart Wealth LLC now owns 58,430 shares of the company’s stock worth $3,450,000 after purchasing an additional 58,414 shares during the period. Bamco Inc. NY increased its stake in Tempus AI by 53.7% in the third quarter. Bamco Inc. NY now owns 263,250 shares of the company’s stock valued at $21,247,000 after purchasing an additional 92,007 shares in the last quarter. Finally, Landscape Capital Management L.L.C. boosted its position in shares of Tempus AI by 19.8% during the 3rd quarter. Landscape Capital Management L.L.C. now owns 136,372 shares of the company’s stock worth $11,007,000 after purchasing an additional 22,581 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.